Beckman Coulter, MeMed Partner on Bacterial and Viral Infection Assay
Beckman Coulter and MeMed are developing a diagnostic assay able to distinguish between bacterial and viral infections.
Read MorePosted by Andy Lundin | Jan 31, 2023 | Immunoassay Reagents & test Kits, Infectious Diseases |
Beckman Coulter and MeMed are developing a diagnostic assay able to distinguish between bacterial and viral infections.
Read MorePosted by Andy Lundin | Jan 6, 2023 | Hematology & Serology |
Precision BioLogic announced FDA 510(k) clearance and the launch of its new CRYOcheck Chromogenic Factor IX assay in the U.S.
Read MorePosted by Andy Lundin | Dec 13, 2022 | Cancer |
A new clinical tool pinpoints which clonal hematopoiesis patients are at highest risk for cancer progression.
Read MorePosted by Andy Lundin | Dec 2, 2022 | Hematology & Serology, Point-of-Care |
HemoSonics has received 510(k) market clearance from the U.S. FDA for the Quantra Hemostasis System with QStatCartridge.
Read MorePosted by Andy Lundin | Nov 28, 2022 | Sexually Transmitted Diseases |
Chembio announced the submission to the FDA for a Clinical Laboratory Improvement Amendments waiver for the DPP HIV-Syphilis System.
Read More